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To develop peptide-conjugated liposomes for cancer imaging and
therapy, the label-free surface plasmon resonance (SPR) biosensor
(Biacore™) is a practical and also preferred strategy to examine
protein-peptide interaction. A new Biacore protocol with “oriented
immobilization” for peptide-binding assay, which overcomes the
drawbacks of conventional protocols, was presented in this data
article. These results were complementary to the research article
Wang at al., [1], which reported a series of new cancer-targeting
peptides found with HotLig software (Wang et al., 2013) [2], and
this newly developed Biacore protocol.
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xperimental
factorsImmobilization of His-tagged proteins on NTA sensor chip with amide linkages.xperimental
featuresPeptide-binding assay using Biacore system with an oriented immobilization
technique.ata source
locationInstitute of Stem Cell and Translational Cancer Research, Chang Gung Memorial
Hospital at Linkou, and Chang Gung University, Taoyuan, Taiwanata accessibility Data are with this articleD The new Biacore strategy provided an alternative method which improved the stability of baseline
and the sensitivity of peptide-binding assay.
 Immobilization of protein with deﬁned orientation on sensor chip might be more favorable for
analyzing molecular interactions.
 The slow dissociation rate from GRP78 implicated that the L-peptide and its analogs might be good
candidates for drug-delivery of liposomes to cancer cells.1. Data
This data article presents a Biacore protocol of “oriented immobilization of protein” on sensor chip
(Fig. 1) for peptide-binding assay. The baseline and sensitivity for detecting peptide binding were sig-
niﬁcantly improved by this modiﬁed method (Fig. 2). The binding of two peptides, RLLDTNRPLLPY (L-
peptide) [3] and WIFPWIQL (W) [4], to GRP78 were also compared using this new Biacore protocol (Fig. 3).2. Experimental design, materials and methods
A surface plasmon resonance-based method using the Biacore X platformwas developed to screen
for peptides that targeted human GRP78. The sensor chip NTA, HBS-P buffer (pH 7.4), and the amineid group on the chip NTA was activated by EDC/NHS for amine-coupling with GRP78 at neutral pH
jugated to the N-terminus of GRP78 in order to chelate Ni2þ to NTA-chip surface, thereby orienting
ing domain of GRP78 outwards (see also Fig. 4A in Ref. [1]). The resulting difference in resonance
RP78 was approximately 5515 RU as measured after de-activation with ethanolamine and washing
ing that GRP78 protein was covalently immobilized on chip NTA through amide linkage without
Fig. 2. The baseline and sensitivity for detecting peptide binding were signiﬁcantly improved by the modiﬁed Biacore protocol.
(A) The sensorgram of Biacore assay for L-peptide binding to GRP78 using conventional protocol in which the protein was
immobilized by Ni-chelation to chip NTA. The baseline declined continuously and the sensitivity for detection of peptide
binding was poor, probably because of the loss of GRP78 from the chip. (B) Assay of L-peptide binding to human GRP78 using
our modiﬁed protocol in which the protein was covalently linked to the chip NTA with a deﬁned orientation. The baseline and
sensitivity was stable and the response to peptide binding was dose-dependent. With the concentration of L-peptide ranging
from 6.25 μM to 100 μM for the assay, L-peptide was observed to bind GRP78 with a slow dissociation rate. The KD for L-peptide
was approximately 10 μM, as estimated from ﬁtting the binding curves using BIAevaluation version 4.1 (GE Healthcare) with
default settings.
Fig. 3. The binding of WIFPWIQL (W), a reported GRP78-binding peptide, was also examined. It was found that the W peptide
dissociated from the GRP78 very fast. In contrast, the L-peptide (L) presented a slow rate of dissociation. Both peptides were
evaluated at 50 μM. The analysis of molecular interactions with HotLig as described in Ref. [1,2] indicated that there were seven
hydrogen bonds between L-peptide and GRP78, whereas only one hydrogen bond was found to interact with W peptide.
S.-H. Wang, J. Yu / Data in Brief 7 (2016) 1696–16991698coupling kit (which includes EDC, NHS, and ethanolamine reagents) were all obtained from GE
Healthcare. The sensor chip NTAwas activated using EDC and NHS reagents, according to the standard
procedure for amine coupling. A one-minute pulse of NiCl2 solution (500 μM) was subsequently used
to saturate the chip surface. N-His-tagged GRP78 (about 5 μg protein in 100 μl HBS-P buffer) was then
covalently immobilized to the chip surface NTA under HBS-P buffer. Generally, the resulting differ-
ences in resonance units (RU) were about 50006000 RU. After de-activation with ethanolamine and
washing with EDTA solution (0.35 M, pH 8.3), the prepared sensor chip was applied to Biacore X for
S.-H. Wang, J. Yu / Data in Brief 7 (2016) 1696–1699 1699the binding assay. HBS-P buffer containing 1 mM glycine was used as running buffer. A one-minute
pulse injection of a solution of 20-mM sodium hydroxide dissolved in running buffer was used to
regenerate the chip surface.Acknowledgments
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